These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 29650681)
1. dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence. Santinon G; Brian I; Pocaterra A; Romani P; Franzolin E; Rampazzo C; Bicciato S; Dupont S EMBO J; 2018 Jun; 37(11):. PubMed ID: 29650681 [TBL] [Abstract][Full Text] [Related]
2. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524 [TBL] [Abstract][Full Text] [Related]
3. YAP and TAZ are essential for basal and squamous cell carcinoma initiation. Debaugnies M; Sánchez-Danés A; Rorive S; Raphaël M; Liagre M; Parent MA; Brisebarre A; Salmon I; Blanpain C EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29875149 [TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer. Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Kim M; Kim T; Johnson RL; Lim DS Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714 [TBL] [Abstract][Full Text] [Related]
6. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway. Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507 [TBL] [Abstract][Full Text] [Related]
7. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125 [TBL] [Abstract][Full Text] [Related]
8. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188 [TBL] [Abstract][Full Text] [Related]
9. The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. Maugeri-Saccà M; Barba M; Pizzuti L; Vici P; Di Lauro L; Dattilo R; Vitale I; Bartucci M; Mottolese M; De Maria R Expert Rev Mol Med; 2015 Jul; 17():e14. PubMed ID: 26136233 [TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ upstream signals and downstream responses. Totaro A; Panciera T; Piccolo S Nat Cell Biol; 2018 Aug; 20(8):888-899. PubMed ID: 30050119 [TBL] [Abstract][Full Text] [Related]
12. YAP/TAZ at the Roots of Cancer. Zanconato F; Cordenonsi M; Piccolo S Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434 [TBL] [Abstract][Full Text] [Related]
13. TAZ and YAP are frequently activated oncoproteins in sarcomas. Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148 [TBL] [Abstract][Full Text] [Related]
14. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501 [TBL] [Abstract][Full Text] [Related]
15. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways. Santinon G; Pocaterra A; Dupont S Trends Cell Biol; 2016 Apr; 26(4):289-299. PubMed ID: 26750334 [TBL] [Abstract][Full Text] [Related]
16. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634 [TBL] [Abstract][Full Text] [Related]
17. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539 [TBL] [Abstract][Full Text] [Related]
18. Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ Inactivation. Oku Y; Nishiya N; Sugiyama S; Sato H; Uehara Y Anticancer Res; 2018 Jun; 38(6):3471-3476. PubMed ID: 29848699 [TBL] [Abstract][Full Text] [Related]